Philip Morris International Announces U.S. FDA Reauthorization of IQOS as a Modified Risk Tobacco Product

Contributed by: Business Wire

Logo

Tags

Other Consumer

Environment

FDA

Other Retail

Natural Disasters

Tobacco

Health

Consumer

Retail

Philip Morris International

More Like This

Philip Morris International Urges U.S. Food and Drug Administration Advisory Committee to Recommend Continued Marketing of IQOS as Modified Risk Product

Philip Morris International Submits Applications to Commercialize IQOS ILUMA Tobacco Heating System to U.S. Food and Drug Administration

Philip Morris International Marks a Decade of IQOS—a Milestone in the Journey to a Smoke-Free Future

Philip Morris International Launches New IQOS ILUMA i in Japan to Accelerate the Achievement of a Smoke-Free Future

Philip Morris International Urges FDA Advisory Committee to Recommend Authorizing ZYN as a Modified Risk Tobacco Product

Governments Need to Keep up with Innovative Breakthroughs to Benefit Public Health, Reveals International Survey Commissioned by PMI

PMI and BAT Announce Global Patent Settlement

Philip Morris International Releases Integrated Report Detailing Progress Towards Its Smoke-Free Vision